SH
Department of Pharmacy PracticeLife SciencesHealth SciencesSocial SciencesPhysical Sciences

Samantha Hollingworth

100 Publications50 Research Themes48 Open Access
Research Overview & Focus

Global health challenges and medication use patterns across diverse settings highlight significant trends in public health interventions. Studies reveal how medication adherence varies by demographics and geographic regions, impacting outcomes like mental health and cardiovascular disease. Advanced pharmacological studies demonstrate the efficacy of drugs in managing chronic conditions such as heart disease and diabetes, while recent epidemiological research underscores the importance of understanding drug use patterns to improve healthcare policies. Furthermore, research on adverse drug reactions highlights the need for robust monitoring systems to prevent harm.

Key Research Themes (50)
Life Sciences

Antibiotic Use and Resistance

Health Sciences

Antifungal resistance and susceptibility

Health Sciences

Attention Deficit Hyperactivity Disorder

Health Sciences

Autoimmune Bullous Skin Diseases

Health Sciences

Birth, Development, and Health

Health Sciences

Bone health and osteoporosis research

Health Sciences

Cardiac electrophysiology and arrhythmias

Social Sciences

Child and Adolescent Psychosocial and Emotional Development

Physical Sciences

Climate Change and Health Impacts

Health Sciences

Dental Anxiety and Anesthesia Techniques

Health Sciences

Diabetes Management and Education

Health Sciences

Diabetes Treatment and Management

Health Sciences

Diet and metabolism studies

Health Sciences

Ethics in Clinical Research

Health Sciences

Gastroesophageal reflux and treatments

Health Sciences

Global Health and Epidemiology

Health Sciences

Global Maternal and Child Health

Social Sciences

Health Systems, Economic Evaluations, Quality of Life

Health Sciences

Healthcare professionals’ stress and burnout

Social Sciences

Healthcare Systems and Reforms

Health Sciences

Heart Failure Treatment and Management

Health Sciences

Infant Nutrition and Health

Health Sciences

Lipoproteins and Cardiovascular Health

Health Sciences

Menopause: Health Impacts and Treatments

Social Sciences

Mental Health Treatment and Access

Health Sciences

Migraine and Headache Studies

Social Sciences

Migration, Health and Trauma

Health Sciences

Multiple Myeloma Research and Treatments

Health Sciences

Multiple Sclerosis Research Studies

Health Sciences

Musculoskeletal pain and rehabilitation

Health Sciences

Nursing Roles and Practices

Health Sciences

Opioid Use Disorder Treatment

Health Sciences

Palliative Care and End-of-Life Issues

Health Sciences

Pancreatic function and diabetes

Health Sciences

Parkinson's Disease Mechanisms and Treatments

Physical Sciences

Pharmaceutical and Antibiotic Environmental Impacts

Social Sciences

Pharmaceutical Economics and Policy

Life Sciences

Pharmaceutical industry and healthcare

Health Sciences

Pharmaceutical Practices and Patient Outcomes

Health Sciences

Pharmaceutical studies and practices

Health Sciences

Pharmacological Effects and Toxicity Studies

Health Sciences

Pharmacology and Obesity Treatment

Life Sciences

Pharmacovigilance and Adverse Drug Reactions

Health Sciences

Primary Care and Health Outcomes

Life Sciences

Reproductive Physiology in Livestock

Health Sciences

Schizophrenia research and treatment

Social Sciences

Sleep and related disorders

Physical Sciences

Statistical Methods in Clinical Trials

Physical Sciences

Traffic and Road Safety

Health Sciences

Treatment of Major Depression

Publications (100)

Economic evaluations of non-communicable diseases conducted in Sub-Saharan Africa: a critical review of data sources

Open Access
2023Health Systems, Economic Evaluations, Quality of LifeDOI: 10.1186/s12962-023-00471-7

Antimicrobial stewardship: Prescribing across the primary care health professions

Open Access
2023Antibiotic Use and ResistanceDOI: 10.1002/prp2.1106

Nurse practitioner and midwife antibiotic prescribing in Australia

Open Access
2023Nursing Roles and PracticesDOI: 10.18332/ejm/162439

Dynamics of Patient-Based Benefit-Risk Assessment of Medicines in Chronic Diseases: A Systematic Review

Open Access
2022Health Systems, Economic Evaluations, Quality of LifeDOI: 10.2147/ppa.s375062

How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review

Open Access
2022Health Systems, Economic Evaluations, Quality of LifeDOI: 10.1080/20477724.2022.2106108

Antibiotic use in Australian and Swedish primary care: a cross-country comparison

Open Access
2022Antibiotic Use and ResistanceDOI: 10.1080/02813432.2022.2036494

Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors

Open Access
2022Cardiac electrophysiology and arrhythmiasDOI: 10.1177/20451253221104947

The impact of COVID-19 on antidepressant sales and prescription dispensing in Australia

2021Healthcare professionals’ stress and burnoutDOI: 10.1177/00048674211068396

Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a content search strategy to retrieve relevant studies

Open Access
2021Statistical Methods in Clinical TrialsDOI: 10.5195/jmla.2022.1306

Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre

Open Access
2021Menopause: Health Impacts and TreatmentsDOI: 10.1186/s12905-021-01478-z

Trends in Systemic Antifungal Use in Australia, 2005–2016: a Time-Series Analysis

Open Access
2021Antifungal resistance and susceptibilityDOI: 10.7883/yoken.jjid.2021.505

Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis

Open Access
2021Health Systems, Economic Evaluations, Quality of LifeDOI: 10.1186/s12962-021-00293-5

Clozapine use and prevalence in Australia 2016–2020

2021Schizophrenia research and treatmentDOI: 10.1177/00048674211025693

Opioid medication prescribing in Queensland, 1997‒2018: a population study

2021Opioid Use Disorder TreatmentDOI: 10.5694/mja2.51115

Using Prescription and Wastewater Data to Estimate the Correction Factors of Atenolol, Carbamazepine, and Naproxen for Wastewater-Based Epidemiology Applications

2021Pharmaceutical and Antibiotic Environmental ImpactsDOI: 10.1021/acs.est.1c00931

Measuring Medicine Use: Applying ATC/DDD Methodology to Real-World Data

Open Access
2021Pharmaceutical Practices and Patient OutcomesDOI: 10.3390/pharmacy9010060

Trends in Australian dental prescribing of antibiotics: 2005–2016

Open Access
2021Antibiotic Use and ResistanceDOI: 10.1111/adj.12846

Disease modifying therapies for relapsing-remitting multiple sclerosis: Use and costs in Australia (1996-2019)

2021Multiple Sclerosis Research StudiesDOI: 10.1016/j.msard.2021.102835

Research governance authorisation: the next frontier

2021Ethics in Clinical ResearchDOI: 10.1071/ah20129

Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study

Open Access
2021Schizophrenia research and treatmentDOI: 10.1177/20451253211000609

Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis

Open Access
2020Schizophrenia research and treatmentDOI: 10.1093/schbul/sbaa191

Community-based integrated care versus hospital outpatient care for managing patients with complex type 2 diabetes: costing analysis*

Open Access
2020Primary Care and Health OutcomesDOI: 10.1071/ah19226

Antidepressant use in Australia and Sweden—A cross‐country comparison

2020Mental Health Treatment and AccessDOI: 10.1002/pds.5158

Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years

2020Opioid Use Disorder TreatmentDOI: 10.1007/s11096-020-01155-5

Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders’ capacity, needs, policy areas of demand and perspectives in Nigeria

Open Access
2020Health Systems, Economic Evaluations, Quality of LifeDOI: 10.1186/s12992-020-00583-2

Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland, Australia

2020Opioid Use Disorder TreatmentDOI: 10.1007/s11096-020-01079-0

Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center

Open Access
2020Autoimmune Bullous Skin DiseasesDOI: 10.1186/s41927-020-00126-7

Health Technology Assessment and priority setting for Universal Health Coverage: A qualitative study of stakeholders capacity, needs, policy areas of demand and perspectives in Nigeria

Open Access
2020Health Systems, Economic Evaluations, Quality of LifeDOI: 10.21203/rs.3.rs-22204/v2

Dental opioid prescribing rates after the up-scheduling of codeine in Australia

Open Access
2020Opioid Use Disorder TreatmentDOI: 10.1038/s41598-020-65390-6

Health technology assessment capacity at national level in sub-Saharan Africa: an initial survey of stakeholders

Open Access
2020Health Systems, Economic Evaluations, Quality of LifeDOI: 10.12688/f1000research.23263.1

Bortezomib use and outcomes for the treatment of multiple myeloma

2020Multiple Myeloma Research and TreatmentsDOI: 10.1111/imj.14886

What do we need to know? Data sources to support evidence-based decisions using health technology assessment in Ghana

Open Access
2020Health Systems, Economic Evaluations, Quality of LifeDOI: 10.1186/s12961-020-00550-8

Multiple opioid prescribers: A genuine quest for treatment rather than aberrant behaviour. A two-decade population-based study

2020Opioid Use Disorder TreatmentDOI: 10.1016/j.addbeh.2020.106458

Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison

2019Gastroesophageal reflux and treatmentsDOI: 10.1007/s00228-019-02798-8

Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process

Open Access
2019Health Systems, Economic Evaluations, Quality of LifeDOI: 10.1017/s0266462319000795

Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?

Open Access
2019Antifungal resistance and susceptibilityDOI: 10.1016/j.ijid.2019.10.016

Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia

Open Access
2019Diet and metabolism studiesDOI: 10.1080/14740338.2019.1674809

Why aren’t Australian pharmacists supplying naloxone? Findings from a qualitative study

2019Opioid Use Disorder TreatmentDOI: 10.1016/j.drugpo.2019.03.020

Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia

2019Menopause: Health Impacts and TreatmentsDOI: 10.1080/13697137.2019.1593357

How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities

Open Access
2019Opioid Use Disorder TreatmentDOI: 10.1016/j.sapharm.2019.03.003

Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal

Open Access
2019Healthcare Systems and ReformsDOI: 10.1177/0046958019887572

Medicine use during acute and chronic postinjury periods in whiplash-injured individuals

Open Access
2018Musculoskeletal pain and rehabilitationDOI: 10.1097/j.pain.0000000000001460

Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life

Open Access
2018Pancreatic function and diabetesDOI: 10.2337/dc18-0261

Forecasting the amount and cost of medicine to treat type 2 diabetes mellitus in Nepal using knowledge on medicine usage from a developed country

2018Pharmaceutical Economics and PolicyDOI: 10.1111/jphs.12265

Does consumer medicines interest reflect medicines use? An observational study comparing medicines call center queries with medicines use

2018Pharmaceutical industry and healthcareDOI: 10.1016/j.sapharm.2018.06.012

Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit

2018Opioid Use Disorder TreatmentDOI: 10.1007/s40264-018-0687-6

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993–2014

2018Schizophrenia research and treatmentDOI: 10.1007/s00213-018-4881-0

Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia.

2018Pharmaceutical Economics and Policy

Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose

2018Opioid Use Disorder TreatmentDOI: 10.1007/s40263-018-0499-3

Treatment of clozapine‐associated obesity and diabetes with exenatide in adults with schizophrenia: <scp>A</scp> randomized controlled trial ( <scp>CODEX</scp> )

2017Pharmacology and Obesity TreatmentDOI: 10.1111/dom.13167

The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies

2017Menopause: Health Impacts and TreatmentsDOI: 10.1097/gme.0000000000000949

Opioid analgesic use in Australia and The Netherlands: a cross-country comparison

2017Opioid Use Disorder TreatmentDOI: 10.1007/s11096-017-0492-9

Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting

2017Multiple Myeloma Research and TreatmentsDOI: 10.1007/s11096-017-0480-0

International trends in clozapine use: a study in 17 countries

Open Access
2017Schizophrenia research and treatmentDOI: 10.1111/acps.12742

Impact of a general practitioner-led integrated model of care on the cost of potentially preventable diabetes-related hospitalisations

2017Primary Care and Health OutcomesDOI: 10.1016/j.pcd.2017.03.009

Prescribing patterns of analgesics and other medicines by dental practitioners in Australia from 2001 to 2012

2017Dental Anxiety and Anesthesia TechniquesDOI: 10.1111/cdoe.12291

The impact of clozapine on hospital use: a systematic review and meta‐analysis

Open Access
2017Schizophrenia research and treatmentDOI: 10.1111/acps.12700

Triptan use in Australia 1997-2015: A pharmacoepidemiological study

2017Migraine and Headache StudiesDOI: 10.1111/ane.12727

Use of Healthcare Services by Patients with Non-Communicable Diseases in Nepal: A Qualitative Study with Healthcare Providers

Open Access
2017Global Health and EpidemiologyDOI: 10.7860/jcdr/2017/25021.9970

Ezetimibe: Use, costs, and adverse events in Australia

Open Access
2016Lipoproteins and Cardiovascular HealthDOI: 10.1111/1755-5922.12236

Case conference primary-secondary care planning at end of life can reduce the cost of hospitalisations

Open Access
2016Palliative Care and End-of-Life IssuesDOI: 10.1186/s12904-016-0157-9

Associations of Guideline Recommended Medications for Acute Coronary Syndromes With Fall-Related Hospitalizations and Cardiovascular Events in Older Women With Ischemic Heart Disease

Open Access
2016Heart Failure Treatment and ManagementDOI: 10.1093/gerona/glw111

A Review of Medication Use as an Indicator of Human Health Impact in Environmentally Stressed Areas

Open Access
2016Climate Change and Health ImpactsDOI: 10.1016/j.aogh.2016.01.010

‘Repeat’ prescriptions and antibiotic resistance: findings from Australian community pharmacy

2016Antibiotic Use and ResistanceDOI: 10.1111/ijpp.12273

Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study

Open Access
2016Migration, Health and TraumaDOI: 10.3399/bjgp16x685249

Prescribing patterns of dental practitioners in Australia from 2001 to 2012. Antimicrobials

Open Access
2016Antibiotic Use and ResistanceDOI: 10.1111/adj.12427

Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes

2016Diabetes Treatment and ManagementDOI: 10.1177/0269881115625496

Pharmacy workforce to prevent and manage non-communicable diseases in developing nations: The case of Nepal

Open Access
2015Pharmaceutical Practices and Patient OutcomesDOI: 10.1016/j.sapharm.2015.09.005

Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy

2015Antibiotic Use and ResistanceDOI: 10.1007/s11096-015-0188-y

Dopamine Agonists: Time Pattern of Adverse Effects Reporting in Australia

Open Access
2015Pharmacovigilance and Adverse Drug ReactionsDOI: 10.1007/s40801-015-0028-3

Clozapine in the community: Improved access or risky free-for-all?

2015Schizophrenia research and treatmentDOI: 10.1177/0004867415592957

Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013

Open Access
2015Schizophrenia research and treatmentDOI: 10.1055/s-0035-1554713

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial

Open Access
2015Diabetes Treatment and ManagementDOI: 10.1192/bjpo.bp.115.001073

Opioid analgesic prescribing in Australia: a focus on gender and age

2015Opioid Use Disorder TreatmentDOI: 10.1002/pds.3767

Clozapine-induced myocarditis: Separating the wheat from the chaff

2014Schizophrenia research and treatmentDOI: 10.1177/0004867414554269

Multiple sclerosis disease modifying medicine utilisation in Australia

2014Multiple Sclerosis Research StudiesDOI: 10.1016/j.jocn.2014.05.034

Effects of decentralisation and health system reform on health workforce and quality‐of‐care in Indonesia, 1993–2007

Open Access
2014Global Maternal and Child HealthDOI: 10.1002/hpm.2255

National trends in the community prescribing of second-generation antipsychotic medications in Australian children and youth: the incomplete story

2013Pharmaceutical studies and practicesDOI: 10.1177/1039856213497809

Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia

Open Access
2013Opioid Use Disorder TreatmentDOI: 10.1111/1753-6405.12030

Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis

2013Multiple Sclerosis Research StudiesDOI: 10.1177/1352458513482371

A new model of integrated primary-secondary care for complex diabetes in the community: study protocol for a randomised controlled trial

Open Access
2013Diabetes Management and EducationDOI: 10.1186/1745-6215-14-382

The prescribing of antiepileptic drugs for pregnant Australian women

2011Pharmacological Effects and Toxicity StudiesDOI: 10.1111/j.1479-828x.2011.01359.x

Psychiatric Drug Prescribing in Elderly Australians: Time for Action

Open Access
2011Health Systems, Economic Evaluations, Quality of LifeDOI: 10.3109/00048674.2011.594947

Utilization of anti‐Parkinson drugs in Australia: 1995–2009

2011Parkinson's Disease Mechanisms and TreatmentsDOI: 10.1002/pds.2114

Australian National Trends in Stimulant Dispensing: 2002–2009

2010Attention Deficit Hyperactivity DisorderDOI: 10.3109/00048674.2010.543413

Prescribing trends in cognition enhancing drugs in Australia

Open Access
2010Pharmaceutical Practices and Patient OutcomesDOI: 10.1017/s1041610210001146

Marked increase in proton pump inhibitors use in Australia

2010Gastroesophageal reflux and treatmentsDOI: 10.1002/pds.1969

Affective and anxiety disorders: prevalence, treatment and antidepressant medication use.

2010Treatment of Major DepressionDOI: 10.3109/00048670903555138

Patterns of Antipsychotic Medication Use in Australia 2002–2007

2010Schizophrenia research and treatmentDOI: 10.3109/00048670903489890

Secondary Prevention of Osteoporosis in Australia

2010Bone health and osteoporosis researchDOI: 10.2165/11318400-000000000-00000

Anxiolytic, hypnotic and sedative medication use in Australia

2010Sleep and related disordersDOI: 10.1002/pds.1899

Changing patterns of antiepileptic drug use in pregnant Australian women

2009Pharmacological Effects and Toxicity StudiesDOI: 10.1111/j.1600-0404.2009.01260.x

Antiepileptic drugs in Australia: 2002–2007

2009Pharmacological Effects and Toxicity StudiesDOI: 10.1002/pds.1871

Sociodemographic correlates of antidepressant utilisation in Australia

2009Child and Adolescent Psychosocial and Emotional DevelopmentDOI: 10.5694/j.1326-5377.2009.tb02522.x

In Australia are people born in other countries at higher risk of road trauma than locally born people?

2003Traffic and Road SafetyDOI: 10.1016/s0001-4575(03)00018-6

Continuous intrafetal infusion of prostaglandin E2 prematurely activates the hypothalamo-pituitary-adrenal axis and induces parturition in sheep.

1996Birth, Development, and HealthDOI: 10.1210/endo.137.6.8641195

Chronic administration of low doses of adrenocorticotropin to hypophysectomized fetal sheep leads to normal term labor.

1994Birth, Development, and HealthDOI: 10.1210/endo.134.3.8119178

Effect of Late Hypothalamo‐Pituitary Disconnection on the Development of the HPA Axis in the Ovine Fetus and the Initiation of Parturition

Open Access
1994Reproductive Physiology in LivestockDOI: 10.1111/j.1365-2826.1994.tb00551.x

The trigger for parturition in sheep: fetal hypothalamus or placenta?

1991Infant Nutrition and Health

Prostaglandin G/H synthase activity in ovine cotyledons: a gestational profile.

1990Reproductive Physiology in Livestock
Academic Metrics
DepartmentDepartment of Pharmacy Practice
Total Publications100
Research Themes50
Open Access Papers48

Department of Pharmacy Practice

Kwame Nkrumah University of Science and Technology

View Department Directory